NewsBang
Search
Sign In
Sign In
Sources
10 Total Sources
Eli Lilly Discloses 7 Retatrutide Arrhythmias and 3 Cardiovascular Events in Late-Stage Trial
Left
50%
Center
50%
All
10
Left
1
Center
1
Others
8
STAT
1d ago
Eli Lilly Reveals Retatrutide Safety Data, Including Arrhythmias and Cardiovascular Complications
StockTitan
1d ago
Eli Lilly retatrutide cuts weight 28.3% in Phase 3 | LLY Stock News
Managed Healthcare Executive
1d ago
Retatrutide shows substantial weight loss, glycemic control in obesity and type 2 diabetes | ADA 2026 | Managed Healthcare Executive
blog.peptide.partners
1d ago
Retatrutide: The Triple Threat That's Rewriting the Rules of Metabolic Medicine
thebiointel.com
12h ago
Eli Lilly Presents New Safety and Tolerability Data on Retatrutide, a Next-Generation Obesity Drug | BioIntel
Reddit
1d ago
Retatrutide
whalesbook.com
5h ago
Eli Lilly's Retatrutide: Beyond Weight Loss, The Real Risks | Whalesbook
Devdiscourse
7h ago
Eli Lilly's Retatrutide: A New Hope for Obesity and Sleep Apnea
health.yahoo.com
1d ago
Why Retatrutide Is Being Called The Next Frontier In Weight Loss Drugs
gethealthspan.com
1d ago
Retatrutide Peptide Dosing: The Triple Agonist Redefining Metabolic Medicine